Health News Articles

Excerpts of key news articles on

Below are key excerpts of revealing news articles on health from reliable news media sources. If any link fails to function, a paywall blocks full access, or the article is no longer available, try these digital tools.

For further exploration, delve into our comprehensive Health and Food Corruption Information Center.

Note: Explore our full index to revealing excerpts of key major media news articles on dozens of engaging topics. And read excerpts from 20 of the most revealing news articles ever published.

Unhealthy food and beverage companies powerfully undermine the eating habits of young people by deploying ubiquitous ads that encourage poor dietary choices and increase the risk of serious disease and premature death, according to a sweeping new study published in Obesity Reviews. The first-of-its-kind summary highlights a clear cumulative pattern: The more high-fat, high-sugar, and salty food ads young people see, the more of those products they consume–and the higher the risk that they may develop obesity, type 2 diabetes, and other diet-related diseases. Companies also disproportionately target adolescents, lower-income communities, and Black and Latino youth with the marketing of health-harming food and beverages. The review summarizes 25 years of scientific evidence and findings from 108 empirical studies and 19 systematic reviews of unhealthy food marketing to adolescents (13-17) and young adults (18-25). One study showed that children who watched just five minutes of food ads ate about 130 more calories that day. Only 19% of studies examined health impacts, but most of those found links between unhealthy food marketing and higher BMI, weight gain, or increased obesity risk–especially from ultra-processed foods and sugary drinks. One U.S. study ... found that children who could recall more food ads chose more food items and consumed more calories after exposure.

Note: For more along these lines, read our concise summaries of news articles on health and food system corruption.

In 2022, three U.S. inspectors showed up unannounced at a massive pharmaceutical plant. For two weeks, they scrutinized humming production lines and laboratories spread across the dense industrial campus, peering over the shoulders of workers. Much of the factory was supposed to be as sterile as an operating room. But the inspectors discovered what appeared to be metal shavings on drugmaking equipment, and records that showed vials of medication that were "blackish" from contamination had been sent to the United States. Quality testing in some cases had been put off for more than six months, according to their report, and raw materials tainted with unknown "extraneous matter" were used anyway, mixed into batches of drugs. Sun Pharma's transgressions were so egregious that the Food and Drug Administration [banned] the factory from exporting drugs to the United States. But ... a secretive group inside the FDA gave the global manufacturer a special pass to continue shipping more than a dozen drugs to the United States even though they were made at the same substandard factory that the agency had officially sanctioned. Pills and injectable medications that otherwise would have been banned went to unsuspecting patients. The same small cadre at the FDA granted similar exemptions to more than 20 other factories that had violated critical standards in drugmaking, nearly all in India.

Note: For more along these lines, read our concise summaries of news articles on Big Pharma corruption.

As a sales rep for drug manufacturers Questcor, Lisa Pratta always suspected the company's business practices weren't just immoral but illegal, too, as she explains in "False Claims – One Insider's Impossible Battle Against Big Pharma Corruption." Pratta began working for Questcor in 2010 as the sales rep in the Northeast region for Acthar, a drug which helped relieve autoimmune and inflammatory disorders. "If prescribed correctly, Acthar could help people walk again. And talk again," writes Pratta. But, she adds, "Questcor made more money when it was prescribed incorrectly." They would do anything to sell Acthar. From paying doctors to prescribe it to using bogus research studies proclaiming its miraculous efficacy, they were so successful that Achtar's price rose from $40 per vial in 2000 to nearly $39,000 in 2019 – an increase of 97,000%. Some sales reps were making up to $4 million a year and, in turn, kept the physicians doing their bidding in a life of luxury. "They took them on scuba diving trips and bought clothes and shoes for their wives. One guy bought his doctor a brand new Armani suit and expensed it to Questcor," she recalls. In March 2019, the Department of Justice served a 100-page lawsuit against Mallinckrodt, alleging illegal marketing of Acthar, bribing doctors to boost sales and defrauding government health care programs. It also mentioned Pratta's role in the case, meaning her long-held anonymity was now public knowledge.

Note: For more along these lines, read our concise summaries of news articles on corruption in science and Big Pharma profiteering.

Colon cancer rates are rocketing among athletic young people in their 20s, 30s, and 40s, and survival rates are dropping. The most convenient explanations for the rise in young colon cancer are diet and weight. We know diet can influence colorectal cancer risk, and it's something people can fix, to a degree. Plus, our diets have changed. These days we all consume more sugar, more ultra-processed foods, more oil and butter, while moving less. Still, doctors say the trend we're seeing now defies neat categories of genetics or lifestyle, and it's baffling. Other factors are clearly messing with our digestive systems, but they're tough to pinpoint. Pollution, microplastics, and artificial light – all are pervasive in society, yet very tricky to study. Something shifted in the 1960s. Everyone born after 1960 has a higher colon cancer risk than previous generations. In the US, young colon cancer rates have been rising about 3% every year since the early 1990s, according to National Cancer Institute data. It's hard to dismiss the role our changing food landscape has played. We are undoubtedly eating worse than our grandparents did 100 years ago. Take fiber, for example. Found in abundance in whole plant foods like beans, it is a nutrient clearly associated with lower risk of cancer. Some of the most popular foods in US supermarkets ... have fiber stripped out during processing, and extra salt, sugar, and oils added in to make them more palatable and shelf-stable.

Note: Read our latest Substack article on how the US government turns a blind eye to the corporate cartels fueling America's health crisis. For more along these lines, read our concise summaries of news articles on health and toxic chemicals.

When Megan Rothbauer suffered a heart attack at work in Wisconsin, she was rushed to hospital in an ambulance. The nearest hospital was "not in network", which left Ms Rothbauer with a $52,531.92 bill for her care. Had the ambulance driven a further three blocks to Meriter Hospital in Madison, the bill would have been a more modest $1,500. The incident laid bare the expensive complexity of the American healthcare system with patients finding that they are uncovered, despite paying hefty premiums, because of their policy's small print. In many cases the grounds for refusal hinge on whether the insurer accepts that the treatment is necessary and that decision is increasingly being made by artificial intelligence rather than a physician. It is leading to coverage being denied on an industrial scale. Much of the work is outsourced, with the biggest operator being EviCore, which ... uses AI to review – and in many cases turn down – doctors' requests for prior authorisation, guaranteeing to pay for treatment. The controversy over coverage denials was brought into sharp focus by the gunning down of UnitedHealthcare's chief executive Brian Thompson in Manhattan. The [words written on the] casings [of] the ammunition – "deny", "defend" and "depose" – are thought to refer to the tactics the insurance industry is accused of using to avoid paying out. UnitedHealthcare rejected one in three claims last year, about twice the industry average.

Note: For more along these lines, read our concise summaries of news articles on AI and corporate corruption.

The House Select Subcommittee on the Coronavirus Pandemic has released its final report, summarizing two years of investigations into the origins and handling of COVID-19. The 520-page report, published Monday, concludes that the virus most likely originated from a laboratory in Wuhan, China. The Republican-led committee cited biological characteristics of the virus and reports of illnesses among researchers at the Wuhan Institute of Virology in late 2019 as key evidence for its findings. The report also scrutinized the World Health Organization (WHO), accusing it of prioritizing the Chinese Communist Party's interests over its global mission to protect public health. The subcommittee criticized U.S. health officials and the Biden administration for what it described as overselling the effectiveness of vaccines in preventing transmission and infection. However, the report praised the early travel restrictions implemented by the Trump administration as a significant step in mitigating the pandemic's spread. This conclusion contrasts with other research pointing to the Huanan Seafood Market in Wuhan as the most likely origin of the virus. The WHO and many scientists have stated that the exact origins of the pandemic remain uncertain. The release of the report highlights the ongoing debate over the pandemic's beginnings and the global response, underscoring the complexities of managing an unprecedented public health crisis.

Note: Watch our Mindful News Brief on the strong evidence that bioweapons research created COVID-19. For more along these lines, read our concise summaries of news articles on COVID corruption and COVID vaccines.

Pfizer Inc. failed to warn patients that its injectable contraceptive drug Depo-Provera can increase the risk of developing brain tumors, a new lawsuit alleged. "For several decades the manufacturers and sellers of Depo-Provera and its authorized generic and generic analogues" had a responsibility to investigate whether the medication could contribute to the growth of brain tumors, according to the complaint filed Monday in the US District Court for the Central District of California. Plaintiff Taylor Devorak alleged that researchers have found Depo-Provera and similar progesterone medications have been linked to a greater incidence of brain tumors called intracranial meningioma. She's seeking damages on her failure-to-warn, defective design, negligence, misrepresentation, and breach of warranty claims against the pharmaceutical giant. Devorak's complaint comes in the wake of a handful of substantially similar lawsuits filed in other federal courts in California and Indiana in recent weeks. The American label for Depo-Provera "still makes no mention of the increased risk to patients of developing intracranial meningiomas," even though the EU and UK now list meningioma under the medication's warning section, Devorak's complaint said. Devorak cited a 2024 study published in the British Medical Journal that said prolonged use of medroxyprogesterone acetate medications like Depo-Provera were found to significantly increase the risk of developing intracranial meningioma.

Note: For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma corruption from reliable major media sources.

A small, tight-knit community of scientific sleuths has been unearthing growing evidence that many studies, including landmark papers published in top journals, contain manipulated images and falsified findings. These revelations have led to high-profile investigations, raised concerns about clinical trials, and culminated in the departure of university presidents. Their work – often posted on PubPeer, a website where users comment on published studies – has also forced a reckoning around how the crushing pressure to publish splashy results incentivizes fraud. "Claire Francis" is a pseudonym for someone who has commented on, by their own reckoning, 20,000 articles since 2010. About 2,000 of these studies were later retracted. Elisabeth Bik ... comments on papers using her real name, and she has earned a reputation for her preternatural ability to spot fishy figures. Bik has flagged issues with about 8,500 studies, contributing to 1,300 retractions and about 1,100 corrections, she told STAT. Those retractions include a study supporting a popular hypothesis for Alzheimer's disease that has been cited more than 2,000 times, as well as a stem cell paper cited nearly 4,500 times. Her work has made her the recipient of more derisive emails, cease-and-desist letters, and legal threats than Bik can count. That's not an uncommon experience, and Bik is an adviser to the Scientific Integrity Fund, which has set aside money to support sleuths being sued for their work.

Note: Top leaders in the field of medicine and science have spoken out about the rampant corruption and conflicts of interest in those industries. For more along these lines, explore concise summaries of revealing news articles on science corruption.

An influential doctor and advocate of adolescent gender treatments said she had not published a long-awaited study of puberty-blocking drugs because of the charged American political environment. The doctor, Johanna Olson-Kennedy, began the study in 2015 as part of a broader, multimillion-dollar federal project on transgender youth. She and colleagues recruited 95 children from across the country and gave them puberty blockers, which stave off the permanent physical changes – like breasts or a deepening voice – that could exacerbate their gender distress, known as dysphoria. The researchers followed the children for two years to see if the treatments improved their mental health. An older Dutch study had found that puberty blockers improved well-being, results that inspired clinics around the world to regularly prescribe the medications as part of what is now called gender-affirming care. But the American trial did not find a similar trend. Puberty blockers did not lead to mental health improvements, she said. In the nine years since the study was funded ... and as medical care for this small group of adolescents became a searing issue in American politics, Dr. Olson-Kennedy's team has not published the data. Asked why, she said the findings might fuel the kind of political attacks that have led to bans of the youth gender treatments in more than 20 states, one of which will soon be considered by the Supreme Court. "I do not want our work to be weaponized," she said.

Note: We believe that everyone has a right to exist and express themselves the way they want. Yet we value the health of all beings and the importance of informed choice when it comes to any potentially life-changing medical procedure. For more along these lines, explore summaries of revealing news articles on transgender medicine from reliable major media sources.

Two lawsuits aim to stop US federal regulators and industry from "illegally" hiding basic information about toxic chemicals used in consumer products. Companies often claim that toxic chemicals' health and safety data, and even their names, are "confidential business information" (CBI) because making the data public could damage their bottom line. The US Environmental Protection Agency frequently allows industry to use the tactic, which makes it virtually impossible for public health researchers to quickly learn about dangerous chemicals. It also bars most EPA staff and state regulators from accessing the information and criminal charges could be brought against those who do. That leaves regulators attempting to protect the public without essential information for some chemicals and in effect creates a "shadow regulatory government" in the EPA, said Tim Whitehouse, a former EPA attorney who is now director of Public Employees for Environmental Responsibility (Peer), a plaintiff in one of the suits. The ... suit alleges the EPA has narrowed Congress's definitions of what should be made public. The EPA is also withholding chemical safety test results that show health risks to the public or environment. Separately, Peer is suing the EPA for hiding health and safety data for chemicals made by Inhance Technologies, which produces plastic containers found to leach dangerous levels of PFOA, a highly toxic compound, into the containers' contents.

Note: For more along these lines, read our concise summaries of news articles on government corruption and toxic chemicals.

The city's ex-COVID czar got the boot from his job at a pharmaceutical firm Monday – a week after he was caught bragging about hosting sex parties and attending an underground rave at the height of the pandemic. Dr. Jay Varma was serving as a senior health adviser to then-Mayor Bill de Blasio during COVID-19 when he and his wife put on the sex- and drug-fueled debauchery and attended a packed Wall Street rave, according to secretly recorded conversations the doctor had with a woman. "Varma boasted about harassing people into submission over the vaccine mandate and admitted to participating in illegal sex parties, all while he, former Health Commissioner Dr. David Chokshi, and then-Mayor Bill de Blasio imposed draconian measures that shut down the entire city," [city Councilman Bob Holden] said. Varma's seamy chats ... were made public last week. Michael Kane of Teachers for Choice said, "What disgusts me the most was hearing Varma say having drug-fueled group sex orgies was necessary for him to be his ‘authentic self' because COVID had him ‘pent up.'" Varma said at one point, "My wife and I had one with our friends in August [2020] of like that first summer." "So we rented a hotel ... we all took, like, you know, molly [MDMA] and like it was like eight or nine or us, eight to 10 of us were in a room and everybody had a blast because everybody was like so pent up."

Note: For more along these lines, see concise summaries of deeply revealing news articles on health and government corruption from reliable major media sources.

Being overweight or obese is a serious, common, and costly chronic disease. More than two in five U.S. adults have obesity. By 2030, nearly one of two adults in the U.S. are projected to be obese. More than 108 million U.S. adults live with obesity and more than 1 billion people are obese around the world. Obesity accounted for nearly $173 billion in medical expenditures in 2019. Recent news that weight loss medications, including GLP-1 receptor agonists like Ozempic and others, are revolutionizing obesity medicine. Some patients lose up to 20 percent of their initial body weight in a year or two on these drugs. Yet a recent lawsuit challenging a top brand heightens concerns about this relatively new class of drugs. More than half of graduating medical students report that the time dedicated to clinical nutrition instruction is insufficient. In a striking study of 115 medical doctors, the majority of participants (65.2 percent) demonstrated inadequate nutrition knowledge, with 30.4 percent of those scoring low having a high self-perception of their nutrition knowledge. The important role of medical doctors in addressing nutrition in clinical practice has been acknowledged by multiple authoritative professional bodies. Ironically, most doctors often lack the knowledge to help a patient eat healthy and to realize the importance of food to wellness. In a contested space filled with commercial interests and influencers, it is critical for a doctor to be a reliable source of evidence-based nutrition.

Note: For more along these lines, see concise summaries of deeply revealing news articles on health and food system corruption from reliable major media sources.

Dr. Robert Lufkin, a physician and father of two young children, has been diagnosed with four chronic diseases – the same ones that claimed his father's life. Inspired by his own medical struggles, Lufkin decided to write a book exposing what he calls "medical lies" that contribute to the risk of chronic disease in the US – some of which he says he himself once taught as a professor at UCLA and USC. His own diagnoses, Lufkin said, "woke him up" to the flaws in the medical system. The doctor noted that ... a "new class of diseases" has posed a challenge. These include obesity, diabetes, hypertension, cancer, cardiovascular disease, Alzheimer's disease and even mental illness, Lufkin said. "Up to 80% of our resources are now spent on these chronic diseases." The tools that were so effective in the 20th century – "the pills and surgeries" – might save lives in the moment. But they only address the symptoms of these chronic diseases – not their root causes. "There's a common metabolic cause that underlies most of these diseases," Lufkin said. Ten percent of American adults have type 2 diabetes, and about 38% have prediabetes. The diabetes lie declares that the best way to treat type 2 diabetes is with insulin. However, it will also raise the body's overall insulin levels, worsening insulin resistance, the underlying cause of type 2 diabetes. Additionally, elevated insulin levels drive other chronic diseases. There are also financial incentives. In 2013, sales of insulin and other diabetes drugs reached $23 billion, according to data from IMS Health, a drug market research firm. That was more than the combined revenue of the National Football League, Major League Baseball and the National Basketball Association.

Note: For more along these lines, see concise summaries of deeply revealing news articles on health from reliable major media sources.

The wellness industry wouldn't be as lucrative if it didn't prey on our insecurities. Young people, disillusioned by polarized politics, saddled with astronomical student loan debt, and burned out by hustle culture, turned to skin care, direct-to-consumer home goods, and food and alcohol delivery – aggressively peddled by companies eager to capitalize on consumers' stressors. While these practices may be restorative in the short term, they fail to address the systemic problems at the heart of individual despair. A certain kind of self-care has come to dominate the past decade, as events like the 2016 election and the Covid pandemic spurred collective periods of anxiety layered on top of existing societal harms. As the self-care industry hit its stride in America, so too did interest in the seemingly dire state of social connectedness. In 2015, a study was published linking loneliness to early mortality. In the years that followed, a flurry of other research illuminated further deleterious effects of loneliness. There is no singular driver of collective loneliness globally. But one practice designed to relieve us from the ills of the world – self-care, in its current form – has pulled us away from one another, encouraging solitude over connection. America's loneliness epidemic is multifaceted, but the rise of consumerist self-care that immediately preceded it seems to have played a crucial role in kicking the crisis into high gear – and now, in perpetuating it. You see, the me-first approach that is a hallmark of today's faux self-care doesn't just contribute to loneliness, it may also be a product of it. Research shows self-centeredness is a symptom of loneliness.

Note: Our latest Substack, Lonely World, Failing Systems: Inspiring Stories Reveal What Sustains Us, dives into the loneliness crisis exacerbated by the digital world and polarizing media narratives, along with inspiring solutions and remedies that remind us of the true democratic values that bring us all together. For more along these lines, read our concise summaries of news articles on corporate corruption and mental health.

In the 1979 murder trial of Dan White, his legal team seemed to attempt to blame his heinous actions on junk-food consumption. The press dubbed the tactic, the "Twinkie defense." Various studies have demonstrated that consuming nutritious, whole foods rather than processed, high-fat, high-sugar foods improves mental health, mood, and academic outcomes. All heavily factor into one's likelihood of committing crime. In the 1980s. Under the direction of a nutritionist, food staff secretly altered the diet at a juvenile detention facility in Virginia to reduce the amount of refined sugar fed to inmates. Social scientist and criminologist Dr. Stephen J. Schoenthaler oversaw the trial. He found that prisoners on the better diet had a 45% lower incidence of documented disciplinary actions. This preliminary success led to a dozen trials at other correctional facilities. "In the twelve correctional institutions that we studied, through 1985, we found that there was a 47% reduction in documented offenses, infractions, and other indicators of antisocial behavior," Schoenthaler said. Is it possible that investing in better prison nutrition would save money overall? Schoenthaler thinks so. "A single preventable infraction that leads to four months of additional jail or prison time might cost us $10,000 or more. If you look at this through the larger lens of prevention and treatment along the entire criminal justice continuum, then the financial savings would be incalculable," he said.

Note: For more along these lines, see concise summaries of deeply revealing news articles on health and prison system corruption from reliable major media sources.

Mexico is fighting to phase out genetically modified (GM) U.S.-grown corn. The Mexican government says this will protect its citizens' health and the country's native corn varieties. Yet the announcement provoked strong objections from the U.S., whose largest annual customer for GM corn is often Mexico–between 2018 and 2020, Mexico bought nearly 30 percent of all U.S. corn exports. The dispute has escalated to formal negotiations under the United States-Mexico-Canada Agreement (USMCA). Mexico ... insists that GM corn threatens human health, and that modified seeds threaten Mexico's agricultural traditions and cultural identity. What began as a wild grass called teosinte nearly 10,000 years ago ... has evolved through millennia of domestication and selective breeding to yield the corn that we know today. Mexico is concerned that GM corn poses the risk of genetic contamination–genes from U.S. corn have a history of crossing the border and entering Mexican varieties. Pollen from GM crops can travel considerable distances and cross-pollinate with the native varieties, potentially altering their genetic makeup and, in some cases, making them less suited to the specific conditions they were bred for. In the U.S., most corn is grown with seed produced by large corporations, which create just a handful of genetically identical corn varieties grown at mass scale.

Note: Read how big agrochemical giant Monsanto worked with US officials to pressure Mexico into abandoning its intended ban on glyphosate. For more along these lines, explore concise summaries of revealing news articles on GMOs and food system corruption from reliable major media sources.

An advertising agency that helped market the blockbuster painkiller OxyContin will pay $350 million to states ravaged by the nation's opioid crisis. Attorneys general from multiple states alleged that Publicis Health developed "unfair and deceptive" marketing campaigns aimed at persuading doctors to prescribe the addictive drug for longer periods of time and at higher doses. The company's client was Purdue Pharma, the Connecticut drugmaker accused in lawsuits of helping ignite the epidemic through aggressive marketing and sales of OxyContin. Publicis, a subsidiary of French ad giant Publicis Groupe, settled with 50 states and D.C. Under the agreements, Publicis Health will stop accepting work related to prescription opioids and must release thousands of internal documents chronicling its dealings with companies such as Purdue. It is the first settlement with an advertising agency connected to the opioid crisis, according to the New York attorney general's office. "Publicis was responsible for creating advertisements and materials, such as pamphlets and brochures that promoted OxyContin as safe and unable to be abused, even though this claim was not true," according to a news release from the office of New York Attorney General Letitia James. Drug overdoses killed nearly 110,000 people in the United States in 2022, a record high, according to federal death statistics.

Note: For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma corruption from reliable major media sources.

Justice Department investigators are scrutinizing the healthcare industry's use of AI embedded in patient records that prompts doctors to recommend treatments. Prosecutors have started subpoenaing pharmaceuticals and digital health companies to learn more about generative technology's role in facilitating anti-kickback and false claims violations, said three sources familiar with the matter.. Two of the sources–speaking anonymously to discuss ongoing investigations–said DOJ attorneys are asking general questions suggesting they still may be formulating a strategy. "I have seen" civil investigative demands "that ask questions about algorithms and prompts that are being built into EMR systems that may be resulting in care that is either in excess of what would have otherwise been rendered, or may be medically unnecessary," said Jaime Jones, who co-leads the healthcare practice at Sidley Austin. DOJ attorneys want "to see what the result is of those tools being built into the system." The probes bring fresh relevance to a pair of 2020 criminal settlements with Purdue Pharma and its digital records contractor, Practice Fusion, over their collusion to design automated pop-up alerts pushing doctors to prescribe addictive painkillers. The kickback scheme ... led to a $145 million penalty for Practice Fusion. Marketers from Purdue ... worked in tandem with Practice Fusion to build clinical decision alerts relying on algorithms.

Note: Read how the US opioid industry operated like a drug cartel. For more along these lines, see concise summaries of deeply revealing news articles on AI and Big Pharma corruption from reliable major media sources.

Medical experts and politicians have called for the amount of antidepressants being prescribed to people across the UK to be reduced in an open letter to the government. The letter coincides with the launch of the all-party parliamentary group Beyond Pills, which aims to reduce what it calls the UK healthcare system's over-reliance on prescription medication. A total of 8.6 million patients in England were prescribed antidepressants in 2022-23, with the amount having almost doubled since 2011. Published in the British Medical Journal ... the letter says: "Rising antidepressant prescribing is not associated with an improvement in mental health outcomes at the population level, which, according to some measures, have worsened as antidepressant prescribing has risen." The letter goes on to say that reducing the rate of antidepressant prescriptions could be achieved through measures that includes stopping the prescribing of antidepressants for mild conditions, and funding and delivering a national 24-hour prescribed drug withdrawal helpline ... to help those experiencing withdrawal symptoms from prescription medication. [Former chief executive of NHS England, Nigel] Crisp said: "The high rate of prescribing of antidepressants over recent years is a clear example of over-medicalisation, where patients are often prescribed unnecessary and potentially harmful drugs instead of tackling the root causes of their suffering, such as loneliness, poverty or poor housing.

Note: Antidepressants are some of the most commonly prescribed medications, yet their significant risks are often withheld from public debate. For more along these lines, see concise summaries of deeply revealing news articles on health and Big Pharma corruption from reliable major media sources.

The European Commission says it has decided to renew the license for the weedkiller compound glyphosate, approving its use in European Union countries for ten more years. Following the decision yesterday, the Commission released a statement saying that, on the basis of comprehensive safety assessments carried out by the European Food Safety Authority (EFSA) and the European Chemicals Agency (ECHA), it would renew the licence, "subject to certain new conditions and restrictions". These include a ban on the use of the chemical to dry crops before harvest, and "the need for certain measures to protect non-target organisms". Governments can still restrict the use of glyphosate in their own countries if they consider the risks too high. Glyphosate is the active ingredient in Roundup, the world's most widely used herbicide. Some studies point to a link between glyphosate and certain cancers. Robin Mesnage, a toxicologist at King's College London, welcomes the Commission's decision to continue to allow the use of glyphosate. Others have expressed disappointment. "It is unacceptable that the Commission still plans to go ahead with its proposal, considering the amount of scientific evidence of the substance's health impacts," says Natacha Cingotti, a campaigner at the Health and Environment Alliance. "While we can't undo the decades of exposure, the Commission can still seize the opportunity to turn the tide towards more sustainable agricultural practices."

Note: For more along these lines, see concise summaries of deeply revealing news articles on corruption in government and in the food system from reliable major media sources.

Important Note: Explore our full index to revealing excerpts of key major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.